VWF and hepatocellular carcinoma: In a previous study, VWF:Ag/ADAMTS13:AC ratio was used as a biomarker of treatment response in HCC patients before the initiation of HAIC treatment, and ROC curves were used to evaluate predictive efficiency, yielding an AUC of 0.715 (Takaya et al. 2020).